This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stock Under $10 that he thinks could potentially double or triple in the next 6 to 12-months. See what he's trading today with a 14-day FREE pass.

Parting Ways With an Old Pal

What's cheap vs. what's expensive? Goldman Sachs today downgraded Kimberly-Clark (KMB), a company that I have liked since 1985, when I first started "using" it, as they say in the biz, with my clients at Goldman Sachs. I found it painful but, alas, probably right.

Kimberly and Heinz (HNZ) were always two of my favorites when I started out in this business because I came of age during a period where the Japanese were ascendant and were stealing so many of our markets that we feared them everywhere we looked, except the kitchen table and the bathroom.

We couldn't envision a scenario where Heinz would be displaced by Mitsubishi ketchup and Kleenex would be trumped by Sumitomo tissues, the two all-powerful conglomerates that strode the world with majesty and power.

This article originally appeared on March 18, 2013, on RealMoney. To read more content like this + see inside Jim Cramer's $3 Million portfolio for FREE Click Here NOW.

Heinz and Kimberly were safe havens, islands that could withstand the onslaught.

Heinz stayed dominant right until the end, the end being Warren Buffet's takeover bid for the company. He has always loved iconic brands and few brands are as iconic as Heinz.

One of them is Kleenex, which, of course, is a name that people call all tissues including the ones I now buy from Costco as the Kirkland brand seemed every bit as good as the Kimberly-Clark version and much cheaper. Kleenex is generic. It's Xerox (XRX) when people used to Xerox.

But I have liked Kimberly-Clarke for more than just its superior product. I have liked it because management has always been incredibly pro-shareholder and has obeyed the social contract that I like so much, a combination of an aggressive buyback and ever-increasing dividends, even when naysayers, of which Goldman Sachs had a total cadre, say that the company can't afford to enforce the contract. I regard the shrinkage in stock, to 393 million shares from 445 million, to be a sign of a meaningful buyback, not a phony one that does little except make up for options granted to management. And the 81-cent quarterly dividend is nothing to sneeze at either.

But in the end, as great as Kimberly-Clark is, the company grows at about 7% but is selling for 17x earnings. I don't like recommending stocks that have a P/E ratio more than twice the growth rate. And while the dividend is outsized, the stock's moved up so much that the yield is only 3.5%, a nice amount but not what I would call a floor by any means, except relative to some of its cohort like Conagra (CAG), Procter (PG) or Kellogg (K).

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
DOW 17,031.14 +43.63 0.26%
S&P 500 1,984.13 -1.41 -0.07%
NASDAQ 4,518.9020 -48.6960 -1.07%

Our Tweets

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs